Synergic Renoprotective Effects of Combined ASC Therapy with RAAS Blockade in Experimental Advanced CKD
Global prevalence of chronic kidney disease (CKD) has increased considerably in the recent decades.Overactivity of the renin-angiotensin-aldosterone system (RAAS), associated to renal inflammation and fibrosis, contributes to its evolution.The treatments currently employed to control CKD progression are limited and mainly based on the pharmacologic